Paper Details

  1. Home
  2. Paper Details

A 5-year study of patients with pulmonary tuberculosis in a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS.

Author: DawsonJ J, DevadattaS, FoxW, RadhakrishnaS, RamakrishnanC V, SomasundaramP R, StottH, TripathyS P, VeluS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 193 patients with tuberculosis compared the effectiveness of home treatment to sanatorium treatment over a five-year period. Both groups showed similar outcomes in terms of relapse rates (7% for home vs. 10% for sanatorium), overall survival, and disease activity at five years. While 5% of home patients and 6% of sanatorium patients died of tuberculosis, the majority of both groups (90% and 89%, respectively) achieved a quiescent state. The study concludes that home treatment is as effective as sanatorium treatment for tuberculosis, particularly in resource-limited settings like India where sanatorium beds are scarce.
Paper Details　
Original Abstract of the Article :
This report from the Tuberculosis Chemotherapy Centre, Madras, summarizes the progress over a 5-year period of 193 patients with newly diagnosed, sputum-positive pulmonary tuberculosis who were admitted to a concurrent comparison of home and sanatorium treatment for one year with isoniazid plus PAS....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475991/

データ提供：米国国立医学図書館（NLM）

Pulmonary Tuberculosis: A Journey Through the Desert of Disease

Dr. Camel has witnessed the devastating impact of tuberculosis, a disease that has plagued humanity for centuries. This study examines the effectiveness of home versus sanatorium treatment for pulmonary tuberculosis, comparing outcomes over a five-year period. The researchers investigate the effectiveness of a one-year regimen of isoniazid plus PAS in patients with newly diagnosed sputum-positive pulmonary tuberculosis.

Navigating the Desert of TB: Home vs. Sanatorium Treatment

The study demonstrates that patients treated at home experienced similar outcomes to those treated in a sanatorium, suggesting that home-based treatment can be equally effective. This finding has significant implications for resource-limited settings where access to sanatoriums is limited.

Finding the Oasis of Effective Treatment: Options for TB Patients

Dr. Camel underscores the importance of providing effective and accessible treatment for tuberculosis. This study highlights the potential of home-based treatment as a viable option for patients in various settings.

Dr. Camel's Conclusion

This research provides valuable insights into the management of pulmonary tuberculosis, emphasizing the effectiveness of home-based treatment and highlighting the need for accessible and affordable care for all patients. The study's findings provide hope for individuals battling this challenging disease.

Date :
  1. Date Completed 1966-10-16
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

5296380

DOI: Digital Object Identifier

PMC2475991

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.